Aspacytarabine( Astarabine | BST-236 | BST236 )

Catalog No. M13324 CAS No. 2098942-53-9

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Get Quotation Bulk Inquiry Add to Cart

Product Name

Aspacytarabine
Note

Research use only, not for human use.
Brief Description

Aspacytarabine (Astarabine, BST236) is a cytarabine conjugate that shows anti-?neoplastic agents for inhibiting cancer cell growth.
Description

Aspacytarabine (Astarabine, BST236) is a cytarabine conjugate that shows anti-?neoplastic agents for inhibiting cancer cell growth. Blood Cancer Phase 2 Clinical.
In Vitro

——
In Vivo

——
Synonyms

Astarabine | BST-236 | BST236
Pathway

Cell Cycle/DNA Damage
Target

Nucleoside Antimetabolite/Analog
Recptor

Nucleoside Antimetabolite/Analog
Research Area

Cancer
Indication

Blood cancer

CAS Number

2098942-53-9
Formula Weight

358.3
Molecular Formula

C13H18N4O8
Purity

>98% (HPLC)
Solubility

——
SMILES

N[C@@H](CC(NC(C=CN1[C@H]2[C@H]([C@@H]([C@@H](CO)O2)O)O)=NC1=O)=O)C(O)=O
Chemical Name

N4-(1-β-D-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin-4-yl)-L-asparagine

1. PCT Int. Appl. (2019), WO 2019012328 A1 20190117.

Calculator

molnova catalog